|Dyadic International, Inc.|
140 Intracoastal Pointe Drive
United States - Map
|Full Time Employees:||11|
Dyadic International, Inc., a biotechnology company, discovers, engages in the discovery, development, manufacture, and sale of enzymes and other proteins in the United States and the Netherlands. It utilizes an integrated technology platform based on its patented and proprietary C1 fungus, which enables the development and manufacture of enzymes and other proteins for various markets. The company offers liquid and dry enzyme products; develops tools for gene expression via its proprietary fungal host, Myceliopthora Thermophila or C1; and provides research and development services for third parties, licenses its technologies. It serves the bioenergy, biochemical, industrial enzyme, biopharmaceutical, animal health and nutrition, pulp and paper, food, and textiles industries. The company was founded in 1979 and is headquartered in Jupiter, Florida.
|Mr. Mark A. Emalfarb ,
Founder, Chief Exec. Officer, Pres, Director and Chairman of Nominating Committee
|Mr. Thomas L. Dubinski CPA,
Chief Financial Officer, VP and Corp. Sec.
|Dr. Ronen Tchelet Ph.D.,
VP of Research & Bus. Devel.
|Mr. Andre Klaassen ,
Director of Marketing & Sales - EMEA
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|